Zydus Lifesciences Ltd.

Zydus Lifesciences’ wholly owned subsidiary -- Zydus MedTech has incorporated a wholly owned subsidiary namely Zydus MedTech (France) SAS on April 10, 2025. Zydus MedTech (France) SAS will be acquiring the equity shares of the Amplitude Surgical SA, France. 

Earlier, Zydus Lifesciences had entered into a put option agreement, share purchase agreements, and other agreements to acquire, directly or through its affiliates, a controlling stake that is 85.6% equity shares (Block Acquisition) of Amplitude Surgical SA, France from the existing shareholders at a price of 6.25 Euro per equity share aggregating to a consideration value of 256.8 million Euro.

Subject to closing of the Block Acquisition, the company would file a mandatory simplified cash tender offer for all the remaining shares in the Amplitude Surgical SA, France, at the same purchase price of 6.25 Euro per equity share of the Amplitude Surgical SA, France. If the conditions are met at the end of the tender offer, the company intends to proceed with a compulsory acquisition of the remaining shares from the minority shareholders (squeeze-out) and to delist the Amplitude Surgical SA, France.

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.